Annual Net Income
-$535.76 M
+$107.44 M+16.70%
December 31, 2024
Summary
- As of February 22, 2025, BBIO annual net profit is -$535.76 million, with the most recent change of +$107.44 million (+16.70%) on December 31, 2024.
- During the last 3 years, BBIO annual net income has risen by +$26.78 million (+4.76%).
- BBIO annual net income is now -1652.86% below its all-time high of -$30.57 million, reached on December 31, 2017.
Performance
BBIO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$162.04 M
-$88.58 M-120.59%
September 30, 2024
Summary
- As of February 22, 2025, BBIO quarterly net profit is -$162.04 million, with the most recent change of -$88.58 million (-120.59%) on September 30, 2024.
- Over the past year, BBIO quarterly net income has increased by +$6.11 million (+3.63%).
- BBIO quarterly net income is now -1544.07% below its all-time high of -$9.86 million, reached on June 30, 2022.
Performance
BBIO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$438.86 M
+$14.96 M+3.30%
September 30, 2024
Summary
- As of February 22, 2025, BBIO TTM net profit is -$438.86 million, with the most recent change of +$14.96 million (+3.30%) on September 30, 2024.
- Over the past year, BBIO TTM net income has increased by +$204.34 million (+31.77%).
- BBIO TTM net income is now -1184.87% below its all-time high of -$34.16 million, reached on March 31, 2018.
Performance
BBIO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
BBIO Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.7% | +3.6% | +31.8% |
| 3 y3 years | +4.8% | +3.6% | +31.8% |
| 5 y5 years | -105.6% | +3.6% | +31.8% |
BBIO Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.3% | +16.7% | -1544.1% | +17.5% | -3.3% | +31.8% |
| 5 y | 5-year | -105.6% | +16.7% | -1544.1% | +17.5% | -68.4% | +31.8% |
| alltime | all time | -1652.9% | +16.7% | -1544.1% | +17.5% | -1184.9% | +31.8% |
BridgeBio Pharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$535.76 M(-16.7%) | - | - |
| Sep 2024 | - | -$162.04 M(+120.6%) | -$438.86 M(-3.3%) |
| Jun 2024 | - | -$73.46 M(+108.6%) | -$453.82 M(-15.7%) |
| Mar 2024 | - | -$35.22 M(-79.1%) | -$538.26 M(-16.3%) |
| Dec 2023 | -$643.20 M(+33.7%) | -$168.15 M(-5.0%) | -$643.20 M(+5.0%) |
| Sep 2023 | - | -$177.00 M(+12.1%) | -$612.64 M(+6.9%) |
| Jun 2023 | - | -$157.90 M(+12.7%) | -$572.99 M(+34.8%) |
| Mar 2023 | - | -$140.16 M(+1.9%) | -$424.94 M(-11.7%) |
| Dec 2022 | -$481.18 M(-14.5%) | -$137.59 M(+0.2%) | -$481.18 M(-2.0%) |
| Sep 2022 | - | -$137.34 M(+1293.5%) | -$490.77 M(-3.7%) |
| Jun 2022 | - | -$9.86 M(-95.0%) | -$509.37 M(-14.5%) |
| Mar 2022 | - | -$196.40 M(+33.4%) | -$595.86 M(+5.9%) |
| Dec 2021 | -$562.54 M | -$147.18 M(-5.6%) | -$562.54 M(+5.1%) |
| Sep 2021 | - | -$155.94 M(+61.8%) | -$535.34 M(+8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$96.35 M(-40.9%) | -$495.27 M(-4.7%) |
| Mar 2021 | - | -$163.08 M(+35.9%) | -$519.95 M(+15.9%) |
| Dec 2020 | -$448.72 M(+72.2%) | -$119.98 M(+3.6%) | -$448.72 M(+11.6%) |
| Sep 2020 | - | -$115.86 M(-4.3%) | -$402.20 M(+16.1%) |
| Jun 2020 | - | -$121.03 M(+31.8%) | -$346.32 M(+18.9%) |
| Mar 2020 | - | -$91.85 M(+25.0%) | -$291.25 M(+11.8%) |
| Dec 2019 | -$260.59 M(+99.3%) | -$73.46 M(+22.5%) | -$260.59 M(+15.4%) |
| Sep 2019 | - | -$59.98 M(-9.1%) | -$225.77 M(+14.5%) |
| Jun 2019 | - | -$65.96 M(+7.8%) | -$197.19 M(+25.0%) |
| Mar 2019 | - | -$61.19 M(+58.3%) | -$157.78 M(+20.7%) |
| Dec 2018 | -$130.75 M(+327.8%) | -$38.64 M(+23.1%) | -$130.75 M(+42.0%) |
| Sep 2018 | - | -$31.40 M(+18.3%) | -$92.11 M(+51.7%) |
| Jun 2018 | - | -$26.55 M(-22.3%) | -$60.71 M(+77.7%) |
| Mar 2018 | - | -$34.16 M | -$34.16 M |
| Dec 2017 | -$30.57 M | - | - |
FAQ
- What is BridgeBio Pharma annual net profit?
- What is the all time high annual net income for BridgeBio Pharma?
- What is BridgeBio Pharma annual net income year-on-year change?
- What is BridgeBio Pharma quarterly net profit?
- What is the all time high quarterly net income for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly net income year-on-year change?
- What is BridgeBio Pharma TTM net profit?
- What is the all time high TTM net income for BridgeBio Pharma?
- What is BridgeBio Pharma TTM net income year-on-year change?
What is BridgeBio Pharma annual net profit?
The current annual net income of BBIO is -$535.76 M
What is the all time high annual net income for BridgeBio Pharma?
BridgeBio Pharma all-time high annual net profit is -$30.57 M
What is BridgeBio Pharma annual net income year-on-year change?
Over the past year, BBIO annual net profit has changed by +$107.44 M (+16.70%)
What is BridgeBio Pharma quarterly net profit?
The current quarterly net income of BBIO is -$162.04 M
What is the all time high quarterly net income for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly net profit is -$9.86 M
What is BridgeBio Pharma quarterly net income year-on-year change?
Over the past year, BBIO quarterly net profit has changed by +$6.11 M (+3.63%)
What is BridgeBio Pharma TTM net profit?
The current TTM net income of BBIO is -$438.86 M
What is the all time high TTM net income for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM net profit is -$34.16 M
What is BridgeBio Pharma TTM net income year-on-year change?
Over the past year, BBIO TTM net profit has changed by +$204.34 M (+31.77%)